跳至主要内容
临床试验/NCT04068844
NCT04068844已完成不适用

Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction

University of Texas Southwestern Medical Center2 个研究点 分布在 1 个国家目标入组 93 人开始时间: 2019年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
93
试验地点
2
主要终点
Aerobic fitness

研究概览

简要总结

The global objective of this study is to determine the mechanisms of exercise intolerance and dyspnea on exertion (DOE) in patients with HFpEF and based on this pathophysiology, test whether specific exercise training programs (whole body vs single leg) will result in improved exercise tolerance.

详细描述

This will be a randomized, non-blinded prospective intervention testing the effects of two types of exercise training, whole body and isolated single leg, on HFpEF patients with either central or peripheral limitations to exercise training. Subjects will undergo baseline maximal exercise testing and invasive right heart catheterization to define exercise tolerance and pulmonary and cardiac pressures during exercise. Based on the results of baseline testing, subjects will be divided into either centrally limited, defined as excessive rise in pulmonary capillary wedge pressure more than 25 mmHg that decreases after administration of sub-lingual nitroglycerin resulting in improved exercise tolerance, or peripherally limited, defined as no improvement in exercise tolerance despite reduction in pulmonary capillary wedge pressure after sublingual nitroglycerin. After baseline testing, subjects will be randomized to either whole body cycle exercise supplemented with sublingual nitroglycerin to improve training responsiveness or isolated single leg exercise training for 4 months. After 4 months, subjects will repeat maximal exercise testing and invasive right heart catheterization to assess responses to 4 months of exercise training.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • signs and symptoms of heart failure
  • an ejection fraction > 0.50
  • objective evidence of diastolic dysfunction

排除标准

  • age < 60 years
  • BMI > 50 kg/m2
  • PDE5 inhibitor use
  • Severe valvular disease
  • Severe COPD
  • CKD 4 or higher
  • Contra-indication to MRI.

研究组 & 干预措施

Central HFpEF whole body exercise

Experimental

HFpEF patients who have a central limitation as the cause of the exercise intolerance randomized to whole body cycle training.

干预措施: Exercise training (Behavioral)

Central HFpEF isolated single leg exercise

Experimental

HFpEF patients who have a central limitation as the cause of the exercise intolerance randomized to isolated single leg training.

干预措施: Exercise training (Behavioral)

Peripheral HFpEF whole body exercise

Experimental

HFpEF patients who have a peripheral limitation as the cause of the exercise intolerance randomized to whole body cycle training.

干预措施: Exercise training (Behavioral)

Peripheral HFpEF isolated single leg exercise

Experimental

HFpEF patients who have a peripheral limitation as the cause of the exercise intolerance randomized to isolated single leg training.

干预措施: Exercise training (Behavioral)

结局指标

主要结局

Aerobic fitness

时间窗: 4 months

Change in peak VO2 after exercise training

次要结局

  • Sympathetic activity(4 months)
  • Cardiac fibrosis(4 months)
  • Cardiopulmonary hemodynamics(4 months)
  • Leg blood flow(4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Benjamin Levine

Professor

University of Texas Southwestern Medical Center

研究点 (2)

Loading locations...

相似试验